Difference between revisions of "CH Basel Balavenkatraman KK"
From Bioblast
Nirschl Lisa (talk | contribs) |
Nirschl Lisa (talk | contribs) |
||
| Line 7: | Line 7: | ||
|Contact=Balavenkatraman Kamal Kumar | |Contact=Balavenkatraman Kamal Kumar | ||
|MiPNetLab=Grueninger Stephan, Weiss Alexander | |MiPNetLab=Grueninger Stephan, Weiss Alexander | ||
|Team previous=Chiesi | |Team previous=Chiesi Michele | ||
|Status=O2k 2007 – | |Status=O2k 2007 – | ||
|info=[[IOC106]], [[IOC39]] | |info=[[IOC106]], [[IOC39]] | ||
Revision as of 14:52, 18 May 2018
CH Basel Balavenkatraman KK
| O2k-Network Lab | Investigator II (iTox-PCS) - Novartis Pharma Ltd., WKL-135.3.21 |
|---|---|
| Address | Klybeckstr 191, 4057 |
| City | Basel |
| State/Prov | |
| Country | Switzerland |
| Weblink | |
| Contact | Balavenkatraman Kamal Kumar |
| Team | Grueninger Stephan, Weiss Alexander |
| Team previous | Chiesi Michele |
| Status | O2k 2007 – |
| Oroboros Events | IOC106, IOC39 |
| Topics |
O2k-Publications
update please
O2k-Abstracts
update please
- Previously CH_Basel_Chiesi M
